MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036

Multicenter, Doubled-blinded, Randomized Phase III trial of Paclitaxel and Carboplatin, with/or without Pembrolizumab and with/or without Olaparib in BRCA wild type Advanced Tubo-Ovarian Carcinoma.